查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601070

微流体市场：按材料、组件、应用和最终用户划分 - 2025-2030 年全球预测

Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年微流体市场价值为255.3亿美元，预计到2024年将达到318.4亿美元，复合年增长率为25.37%，预计到2030年将达到1243.1亿美元。

微流体是工程、物理、化学、生物化学、奈米技术和生物技术交叉领域的跨学科领域，涉及微通道内少量流体的操纵。其范围涵盖多种应用，包括药物开发、临床诊断和环境监测，为医疗保健、製药和环境科学等产业做出贡献。微流体的需求在于能够以减少的样品和试剂体积执行高效且经济高效的分析，并提供快速结果。它们的应用范围广泛，但在医疗保健服务分散化和快速诊断需求不断增长的推动下，它们在就地检验、病原体检测和个人化医疗方面尤其重要。

主要市场统计
基准年[2023] 255.3亿美元
预测年份 [2024] 318.4亿美元
预测年份 [2030] 1243.1亿美元
复合年增长率（%） 25.37%

影响微流体市场的主要成长要素包括微型化技术的进步、研发资金的增加以及需要创新诊断解决方案的慢性疾病盛行率的上升。微流体与人工智慧和机器学习的整合带来了巨大的商机，特别是在智慧和自主实验室晶片设备的开发方面。为了利用这些机会，相关人员应专注于跨学科合作并扩大其自动化数位化能力。

然而，设备高成本、製造流程复杂、监管要求严格等挑战可能会阻碍市场成长。克服这些限制需要对扩充性的製造技术进行策略性投资并简化监管途径。需要创新的领域包括开发用于家庭医疗环境的低成本、易于使用的微流体系统，以及探索新材料，例如纸基微流体，以实现永续性和降低成本。

微流体市场以技术创新快、竞争激烈为特点，可望实现显着成长。公司应致力于策略併购，以加强产品系列和地理覆盖范围。随着对可携式快速诊断解决方案的需求增加，专注于开拓具有更高灵敏度和特异性的整合系统将帮助您在不断变化的市场环境中占据主导。

市场动态：揭示快速发展的微流体市场的关键市场洞察

供需的动态交互作用正在改变微流体市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病盛行率不断上升，对就地检验的需求增加
    • 微流体晶片的小型化提高了设备的便携性并减少了分析时间
    • 使用微流体进行药物传递的应用的可能性
  • 市场限制因素
    • 复杂而漫长的监管核准流程
  • 市场机会
    • 开发基于微流体的 3D 细胞培养系统，例如晶片器官
    • 用于生物医学分析和诊断的微流体组件的进展
  • 市场挑战
    • 微流体与现有工作流程的集成

波特五力：驾驭微流体市场的战略工具

波特的五力框架是了解微流体市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解微流体市场的外部影响

外部宏观环境因素在塑造微流体市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解微流体市场的竞争格局

对微流体市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵微流体市场供应商绩效评估

FPNV定位矩阵是评估微流体市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的增加和对就地检验的需求
      • 微流体晶片的小型化提高了设备的便携性并缩短了分析週转时间
      • 使用微流体进行药物传输的潜在应用
    • 抑制因素
      • 复杂而漫长的监管核准流程
    • 机会
      • 开发基于微流体的 3D 细胞培养系统，例如器官晶片
      • 用于生物医学分析和诊断的微流体组件的进展
    • 任务
      • 微流体与现有工作流程的集成
  • 市场区隔分析
    • 材料：微流体装置中玻璃和硅基材料的使用增加
    • 组成部分：采用微针和帮浦以最大限度地降低感染风险
    • 应用：微流体装置在 IVD 与治疗上的重要应用
    • 最终使用者：微流体在研究机构、医院和诊断中心的新用途
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章微流体市场：依材料分类

  • 玻璃底座
  • 聚合物基
  • 硅胶底座

第七章微流体市场：依组成部分

  • 微型针
  • 微型帮浦
  • 微流体晶片

第八章微流体市场：依应用分类

  • 体外诊断
    • 临床诊断
    • 就地检验
    • 兽医诊断
  • 製药与生命科学研究
    • 实验室分析
      • 毛细管电泳
      • 基于细胞的检测
      • 基因组分析
      • 蛋白质体分析
    • 微量点胶
    • 微反应
  • 治疗药物
    • 药物输送
    • 穿戴式装置

第 9 章微流体市场：依最终用户分类

  • 学术研究所
  • 医院和诊断中心
  • 製药和生物技术公司

第10章美洲微流体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区微流体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲微流体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Astravaeus 在种子轮融资中筹集了 1,650 万欧元，以推进自动化微流体细胞和基因治疗製造平台的开发
    • Biotechne 将收购瑞士空间生物学公司 Lunaphor
    • CellFE 宣布在 ASGCT 2023 年会上展示新的微流体细胞工程平台

公司名单

  • Abbott Laboratories
  • Ascent Bio-Nano Technologies, Inc.
  • Camozzi Automation SpA
  • Dolomite Microfluidics
  • IMT Masks and Divisions AG
  • PerkinElmer Inc.
  • Thermo Fisher Scientific, Inc.
  • Mission Bio, Inc.
  • Idex Corporation
  • NanoCellect Biomedical.
  • Abaxis, Inc.
  • Quidel Corporation
  • Koninklijke Philips NV
  • Parker-Hannifin Corporation
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioFluidica
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Biosurfit SA
  • SMC Corporation
  • Micropoint Bioscience, Inc.
  • Fluigent SA
  • Elvesys Group
  • Achira Labs Pvt. Ltd.
  • Sphere Fluidics Limited
  • OPKO Health, Inc.
  • Cellix Limited
  • AbCellera Biologics Inc.
  • Fluidigm Corporation by Standard BioTools Inc.
Product Code: MRR-036C5CF3A81A

The Microfluidics Market was valued at USD 25.53 billion in 2023, expected to reach USD 31.84 billion in 2024, and is projected to grow at a CAGR of 25.37%, to USD 124.31 billion by 2030.

Microfluidics, a multidisciplinary field intersecting engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, involves the manipulation of small volumes of fluids in micro-channels. Its scope extends across various applications such as drug development, clinical diagnostics, and environmental monitoring, serving industries including healthcare, pharmaceuticals, and environmental science. The necessity of microfluidics arises from its ability to conduct high-efficiency, cost-effective analyses with reduced sample and reagent volumes, thus providing rapid results. Its applications are broad but are particularly pivotal in point-of-care testing, pathogen detection, and personalized medicine, driven by the growing demand for decentralizing healthcare services and rapid diagnostics.

KEY MARKET STATISTICS
Base Year [2023] USD 25.53 billion
Estimated Year [2024] USD 31.84 billion
Forecast Year [2030] USD 124.31 billion
CAGR (%) 25.37%

Key growth factors influencing the microfluidics market include advancements in miniaturization technologies, increased funding for research and development, and the rising prevalence of chronic diseases necessitating innovative diagnostic solutions. The integration of microfluidics with AI and machine learning presents substantial opportunities, especially in developing smart, autonomous lab-on-a-chip devices. To capitalize on these opportunities, stakeholders should focus on interdisciplinary collaborations and expanding capabilities in automation and digitization.

However, challenges such as the high cost of devices, complex manufacturing processes, and stringent regulatory requirements can impede market growth. Overcoming these limitations will require strategic investments in scalable manufacturing technologies and streamlined regulatory pathways. Areas ripe for innovation include developing low-cost, user-friendly microfluidics systems for home healthcare settings, and exploring new materials like paper-based microfluidics for sustainability and cost reduction.

The microfluidics market, characterized by rapid technological advancements and a high degree of competition, offers substantial growth prospects. Companies should target strategic mergers and acquisitions to enhance their product portfolios and geographical reach. Insights indicate that as the demand for portable and rapid diagnostic solutions increases, emphasizing the development of integrated systems with enhanced sensitivity and specificity can position businesses for leadership in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Microfluidics Market

The Microfluidics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
    • Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
    • Potential Applications of Drug Delivery using Microfluidics
  • Market Restraints
    • Complicated and Time-Consuming Regulatory Approval Process
  • Market Opportunities
    • Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
    • Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
  • Market Challenges
    • Integration of Microfluidics with Existing Workflows

Porter's Five Forces: A Strategic Tool for Navigating the Microfluidics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Microfluidics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Microfluidics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Microfluidics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Microfluidics Market

A detailed market share analysis in the Microfluidics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Microfluidics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Microfluidics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ascent Bio-Nano Technologies, Inc., Camozzi Automation S.p.A., Dolomite Microfluidics, IMT Masks and Divisions AG, PerkinElmer Inc., Thermo Fisher Scientific, Inc., Mission Bio, Inc., Idex Corporation, NanoCellect Biomedical., Abaxis, Inc., Quidel Corporation, Koninklijke Philips N.V., Parker-Hannifin Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Agilent Technologies, Inc., Danaher Corporation, Biosurfit SA, SMC Corporation, Micropoint Bioscience, Inc., Fluigent S.A., Elvesys Group, Achira Labs Pvt. Ltd., Sphere Fluidics Limited, OPKO Health, Inc., Cellix Limited, AbCellera Biologics Inc., and Fluidigm Corporation by Standard BioTools Inc..

Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material, market is studied across Glass-based, Polymer-based, and Silicon-based.
  • Based on Component, market is studied across Micro Needle, Micro Pump, and Microfluidic Chip.
  • Based on Application, market is studied across In-Vitro Diagnostics, Pharmaceutical & Life Science Research, and Therapeutics. The In-Vitro Diagnostics is further studied across Clinical Diagnostics, Point-Of-Care Testing, and Veterinary Diagnostics. The Pharmaceutical & Life Science Research is further studied across Lab Analytics, Microdispensing, and Microreaction. The Lab Analytics is further studied across Capillary Electrophoresis, Cell-based Assays, Genomic analysis, and Proteomic Analysis. The Therapeutics is further studied across Drug Delivery and Wearable Devices.
  • Based on End User, market is studied across Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
      • 5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
      • 5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
      • 5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Integration of Microfluidics with Existing Workflows
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Material: Increasing use of glass and silicon-based materials for microfluidic devices
    • 5.2.2. Component: Adoption of microneedles and pumps for minimal risk of infection
    • 5.2.3. Application: Significant application of microfluidic devices in IVD and therapeutics
    • 5.2.4. End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Microfluidics Market, by Material

  • 6.1. Introduction
  • 6.2. Glass-based
  • 6.3. Polymer-based
  • 6.4. Silicon-based

7. Microfluidics Market, by Component

  • 7.1. Introduction
  • 7.2. Micro Needle
  • 7.3. Micro Pump
  • 7.4. Microfluidic Chip

8. Microfluidics Market, by Application

  • 8.1. Introduction
  • 8.2. In-Vitro Diagnostics
    • 8.2.1. Clinical Diagnostics
    • 8.2.2. Point-Of-Care Testing
    • 8.2.3. Veterinary Diagnostics
  • 8.3. Pharmaceutical & Life Science Research
    • 8.3.1. Lab Analytics
      • 8.3.1.1. Capillary Electrophoresis
      • 8.3.1.2. Cell-based Assays
      • 8.3.1.3. Genomic analysis
      • 8.3.1.4. Proteomic Analysis
    • 8.3.2. Microdispensing
    • 8.3.3. Microreaction
  • 8.4. Therapeutics
    • 8.4.1. Drug Delivery
    • 8.4.2. Wearable Devices

9. Microfluidics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Diagnostic Centers
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Microfluidics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Microfluidics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Microfluidics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
    • 13.3.2. Bio-Techne to acquire Swiss spatial biology firm Lunaphore
    • 13.3.3. CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Ascent Bio-Nano Technologies, Inc.
  • 3. Camozzi Automation S.p.A.
  • 4. Dolomite Microfluidics
  • 5. IMT Masks and Divisions AG
  • 6. PerkinElmer Inc.
  • 7. Thermo Fisher Scientific, Inc.
  • 8. Mission Bio, Inc.
  • 9. Idex Corporation
  • 10. NanoCellect Biomedical.
  • 11. Abaxis, Inc.
  • 12. Quidel Corporation
  • 13. Koninklijke Philips N.V.
  • 14. Parker-Hannifin Corporation
  • 15. Illumina, Inc.
  • 16. Bio-Rad Laboratories, Inc.
  • 17. BioFluidica
  • 18. Agilent Technologies, Inc.
  • 19. Danaher Corporation
  • 20. Biosurfit SA
  • 21. SMC Corporation
  • 22. Micropoint Bioscience, Inc.
  • 23. Fluigent S.A.
  • 24. Elvesys Group
  • 25. Achira Labs Pvt. Ltd.
  • 26. Sphere Fluidics Limited
  • 27. OPKO Health, Inc.
  • 28. Cellix Limited
  • 29. AbCellera Biologics Inc.
  • 30. Fluidigm Corporation by Standard BioTools Inc.

LIST OF FIGURES

  • FIGURE 1. MICROFLUIDICS MARKET RESEARCH PROCESS
  • FIGURE 2. MICROFLUIDICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MICROFLUIDICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MICROFLUIDICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MICROFLUIDICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MICROFLUIDICS MARKET DYNAMICS
  • TABLE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY GLASS-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY SILICON-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO NEEDLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROFLUIDIC CHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MICROFLUIDICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MICROFLUIDICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MICROFLUIDICS MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MICROFLUIDICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MICROFLUIDICS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MICROFLUIDICS MARKET SIZE, BY GENOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MICROFLUIDICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRODISPENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROREACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MICROFLUIDICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MICROFLUIDICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MICROFLUIDICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MICROFLUIDICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)

TABLE